Eleutheroside E

CAS No. 39432-56-9

Eleutheroside E ( —— )

Catalog No. M18518 CAS No. 39432-56-9

Eleutheroside E has anti-inflammatory effects by inhibiting NF-κB activities.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
5MG 76 In Stock
10MG 98 In Stock
25MG 217 In Stock
50MG 350 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eleutheroside E
  • Note
    Research use only, not for human use.
  • Brief Description
    Eleutheroside E has anti-inflammatory effects by inhibiting NF-κB activities.
  • Description
    Eleutheroside E has anti-inflammatory effects by inhibiting NF-κB activities. Eleutheroside E significantly decreases the inflammatory cell infiltration, pannus formation, cartilage damage, bone erosion of CIA mice, the generation of TNF-α and IL-6, the metabolism of drugs metabolized via CYP2C9 and CYP2E1. Eleutheroside E may treat rheumatoid arthritis or increase the toxicity of the drugs.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    NF-κB
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    39432-56-9
  • Formula Weight
    742.73
  • Molecular Formula
    C34H46O18
  • Purity
    98%
  • Solubility
    DMSO : ≥ 7.5 mg/mL; 10.10 mM
  • SMILES
    COc1cc(cc(c1O[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)OC)[C@@H]1[C@H]2CO[C@H]([C@H]2CO1)c1cc(c(c(c1)OC)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kil YS, et al. Arch Pharm Res. 2015 Nov;38(11):1921-5.
molnova catalog
related products
  • VU0238441

    VU0238441 is agonist of Muscarinic acetylcholine receptor M5 (human) with?EC50 of 2.1μM.

  • Decamethonium bromid...

    Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.

  • CCMI

    CCMI is a potent and selective modulator of α7 nAChR-positive allosteric.